Stock ADDV B ADDVISE GROUP AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings ADDvise Group AB Nasdaq Stockholm

Equities

ADDV B

SE0007464862

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:57 2024-06-07 EDT 		5-day change 1st Jan Change
8.04 SEK +1.52% Intraday chart for ADDvise Group AB -1.35% -41.06%
05-21 ADDvise Group AB Receives Order Worth USD 1.4 Million CI
05-03 ADDvise Group AB Announces Board Appointments CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • One of the major weak points of the company is its financial situation.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ADDVISE GROUP AB Stock ADDvise Group AB
-41.06% 156M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.26% 187B
C+
MEDTRONIC PLC Stock Medtronic plc
+2.05% 110B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-1.31% 69.54B
A
CENCORA, INC. Stock Cencora, Inc.
+14.65% 46.37B
B-
DEXCOM, INC. Stock DexCom, Inc.
-6.69% 46.05B
B-
HOYA CORPORATION Stock Hoya Corporation
+7.97% 42.54B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+18.60% 30.72B
B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-6.87% 23.32B
B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-10.63% 22.92B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. ADDV A Stock
  4. ADDV B Stock
  5. Ratings ADDvise Group AB